Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung.

PubWeight™: 3.54‹?› | Rank: Top 1%

🔗 View Article (PMC 1979160)

Published in Nat Biotechnol on March 04, 2007

Authors

Phil Oh1, Per Borgström, Halina Witkiewicz, Yan Li, Bengt J Borgström, Adrian Chrastina, Koji Iwata, Kurt R Zinn, Richard Baldwin, Jacqueline E Testa, Jan E Schnitzer

Author Affiliations

1: Sidney Kimmel Cancer Center, 10905 Road to the Cure, San Diego, California 92121, USA.

Articles citing this

Endocytosis of nanomedicines. J Control Release (2010) 3.23

Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol (2009) 3.01

Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis (2008) 2.99

Caveolae as plasma membrane sensors, protectors and organizers. Nat Rev Mol Cell Biol (2013) 2.98

Control of endothelial targeting and intracellular delivery of therapeutic enzymes by modulating the size and shape of ICAM-1-targeted carriers. Mol Ther (2008) 2.69

Endothelial-derived angiocrine signals induce and sustain regenerative lung alveolarization. Cell (2011) 2.42

Immune Monitoring of Trans-endothelial Transport by Kidney-Resident Macrophages. Cell (2016) 2.12

Single chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imaging. Small (2009) 1.93

More effective nanomedicines through particle design. Small (2011) 1.80

Molecular mechanisms of clathrin-independent endocytosis. J Cell Sci (2009) 1.72

Stealth nanoparticles: high density but sheddable PEG is a key for tumor targeting. J Control Release (2010) 1.64

Understanding and overcoming major barriers in cancer nanomedicine. Nanomedicine (Lond) (2010) 1.51

Molecular imaging of pancreatic cancer in an animal model using targeted multifunctional nanoparticles. Gastroenterology (2009) 1.47

Imaging cell biology in live animals: ready for prime time. J Cell Biol (2013) 1.35

Size and dynamics of caveolae studied using nanoparticles in living endothelial cells. ACS Nano (2009) 1.33

Flow dynamics, binding and detachment of spherical carriers targeted to ICAM-1 on endothelial cells. Biorheology (2009) 1.32

Vessel microport technique for applications in cerebrovascular research. J Neurosci Res (2009) 1.28

Clathrin-independent pathways of endocytosis. Cold Spring Harb Perspect Biol (2014) 1.25

Deletion of cavin genes reveals tissue-specific mechanisms for morphogenesis of endothelial caveolae. Nat Commun (2013) 1.24

Caveolae, caveolins, cavins, and endothelial cell function: new insights. Front Physiol (2012) 1.20

Targeting receptor-mediated endocytotic pathways with nanoparticles: rationale and advances. Adv Drug Deliv Rev (2012) 1.18

Targeted delivery of therapeutics to endothelium. Cell Tissue Res (2008) 1.10

Insight into nanoparticle cellular uptake and intracellular targeting. J Control Release (2014) 1.08

Small-molecule delivery by nanoparticles for anticancer therapy. Trends Mol Med (2010) 1.07

Challenges in design and characterization of ligand-targeted drug delivery systems. J Control Release (2012) 1.07

Combinatorial ligand-directed lung targeting. Proc Am Thorac Soc (2009) 1.07

Delivery of nanoparticle: complexed drugs across the vascular endothelial barrier via caveolae. IUBMB Life (2011) 1.05

Barriers to non-viral vector-mediated gene delivery in the nervous system. Pharm Res (2011) 1.04

Endocytosis of gene delivery vectors: from clathrin-dependent to lipid raft-mediated endocytosis. Mol Ther (2013) 1.03

Endocytic crosstalk: cavins, caveolins, and caveolae regulate clathrin-independent endocytosis. PLoS Biol (2014) 1.02

A potential role of distinctively delayed blood clearance of recombinant adeno-associated virus serotype 9 in robust cardiac transduction. Mol Ther (2011) 1.00

Enhancing identifications of lipid-embedded proteins by mass spectrometry for improved mapping of endothelial plasma membranes in vivo. Mol Cell Proteomics (2009) 0.99

Designed auto-assembly of nanostreptabodies for rapid tissue-specific targeting in vivo. J Biol Chem (2009) 0.95

Creating perfused functional vascular channels using 3D bio-printing technology. Biomaterials (2014) 0.93

Immunotargeting and cloning of two CD34 variants exhibiting restricted expression in adult rat endothelia in vivo. Am J Physiol Lung Cell Mol Physiol (2009) 0.92

Vascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigm. ACS Nano (2014) 0.92

The utilization of pathogen-like cellular trafficking by single chain block copolymer. Biomaterials (2009) 0.91

Loss of caveolin-1 causes blood-retinal barrier breakdown, venous enlargement, and mural cell alteration. Am J Pathol (2013) 0.90

Endothelial targeting of polymeric nanoparticles stably labeled with the PET imaging radioisotope iodine-124. Biomaterials (2012) 0.89

"Alternative" endocytic mechanisms exploited by pathogens: new avenues for therapeutic delivery? Adv Drug Deliv Rev (2007) 0.89

3-D photoacoustic and pulse echo imaging of prostate tumor progression in the mouse window chamber. J Biomed Opt (2011) 0.88

Nanotechnology: toxicologic pathology. Toxicol Pathol (2013) 0.87

Lung vascular targeting using antibody to aminopeptidase P: CT-SPECT imaging, biodistribution and pharmacokinetic analysis. J Vasc Res (2010) 0.87

Caveolae protect endothelial cells from membrane rupture during increased cardiac output. J Cell Biol (2015) 0.86

Targeted drug delivery to tumor vasculature by a carbohydrate mimetic peptide. Proc Natl Acad Sci U S A (2011) 0.86

Contributions of quantitative proteomics to understanding membrane microdomains. J Lipid Res (2009) 0.86

Assessing the barriers to image-guided drug delivery. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2013) 0.86

Noninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects. Chem Rev (2015) 0.85

Endothelin induces rapid, dynamin-mediated budding of endothelial caveolae rich in ET-B. J Biol Chem (2012) 0.84

Effects of different tissue microenvironments on gene expression in breast cancer cells. PLoS One (2014) 0.84

Overcoming key technological challenges in using mass spectrometry for mapping cell surfaces in tissues. Mol Cell Proteomics (2010) 0.84

Ubiquitous yet distinct expression of podocalyxin on vascular surfaces in normal and tumor tissues in the rat. J Vasc Res (2009) 0.83

NCI Image-Guided Drug Delivery Summit. Cancer Res (2011) 0.83

Targeting antioxidant and antithrombotic biotherapeutics to endothelium. Semin Thromb Hemost (2010) 0.83

The cargo of CRPPR-conjugated liposomes crosses the intact murine cardiac endothelium. J Control Release (2012) 0.83

Vascular targeting via caveolae. Nat Biotechnol (2007) 0.83

Intravital microscopy in the mouse dorsal chamber model for the study of solid tumors. Am J Cancer Res (2011) 0.83

Parameters and characteristics governing cellular internalization and trans-barrier trafficking of nanostructures. Int J Nanomedicine (2015) 0.82

Nanocarriers for vascular delivery of anti-inflammatory agents. Annu Rev Pharmacol Toxicol (2014) 0.81

Targeting and imaging signature caveolar molecules in lungs. Proc Am Thorac Soc (2009) 0.81

Imaging the dynamics of endocytosis in live mammalian tissues. Cold Spring Harb Perspect Biol (2014) 0.81

High-resolution, serial intravital microscopic imaging of nanoparticle delivery and targeting in a small animal tumor model. Nano Today (2013) 0.80

Transendothelial movement and caveolae. Nat Biotechnol (2008) 0.79

Molecular imaging of the pulmonary circulation in health and disease. Clin Transl Imaging (2014) 0.79

Polymeric nanoparticles in development for treatment of pulmonary infectious diseases. Wiley Interdiscip Rev Nanomed Nanobiotechnol (2016) 0.78

Non-affinity factors modulating vascular targeting of nano- and microcarriers. Adv Drug Deliv Rev (2015) 0.78

Targeted therapeutics and nanodevices for vascular drug delivery: quo vadis? IUBMB Life (2011) 0.78

Caveolin-1 phosphorylation regulates vascular endothelial insulin uptake and is impaired by insulin resistance in rats. Diabetologia (2015) 0.77

Targeted endothelial nanomedicine for common acute pathological conditions. J Control Release (2015) 0.77

Distinct subcellular trafficking resulting from monomeric vs multimeric targeting to endothelial ICAM-1: implications for drug delivery. Mol Pharm (2014) 0.76

I. Embryonal vasculature formation recapitulated in transgenic mammary tumor spheroids implanted pseudo-orthotopicly into mouse dorsal skin fold: the organoblasts concept. F1000Res (2013) 0.76

Co-implanting orthotopic tissue creates stroma microenvironment enhancing growth and angiogenesis of multiple tumors. F1000Res (2013) 0.76

Systems analysis of endothelial cell plasma membrane proteome of rat lung microvasculature. Proteome Sci (2011) 0.76

Systemically Administered, Target Organ-Specific Therapies for Regenerative Medicine. Int J Mol Sci (2015) 0.76

Size-dependent cellular uptake mechanism and cytotoxicity toward calcium oxalate on Vero cells. Sci Rep (2017) 0.75

Caveolin-1 regulates Rac1 activation and rat pulmonary microvascular endothelial hyperpermeability induced by TNF-α. PLoS One (2013) 0.75

Construction of metabolically biotinylated adenovirus with deleted fiber knob as targeting vector. Virol J (2010) 0.75

Imaging of molecular signatures of specific structures, functions,and pathological alterations in the lung tissue.Chair's Summary. Proc Am Thorac Soc (2009) 0.75

Tumor targeting, trifunctional dendritic wedge. Bioconjug Chem (2014) 0.75

Overexpression of caveolin-1 in inflammatory breast cancer cells enables IBC-specific gene delivery and prodrug conversion using histone-targeted polyplexes. Biotechnol Bioeng (2016) 0.75

Caveolins and caveolae in ocular physiology and pathophysiology. Prog Retin Eye Res (2016) 0.75

Targeting the vascular and perivascular niches as a regenerative therapy for lung and liver fibrosis. Sci Transl Med (2017) 0.75

Articles cited by this

A lentiviral RNAi library for human and mouse genes applied to an arrayed viral high-content screen. Cell (2006) 18.81

Caveolar endocytosis of simian virus 40 reveals a new two-step vesicular-transport pathway to the ER. Nat Cell Biol (2001) 8.93

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science (2001) 8.53

Caveolin-1 null mice are viable but show evidence of hyperproliferative and vascular abnormalities. J Biol Chem (2001) 7.03

Separation of caveolae from associated microdomains of GPI-anchored proteins. Science (1995) 5.25

Organ targeting in vivo using phage display peptide libraries. Nature (1996) 5.20

Ultrastructural localization of gangliosides; GM1 is concentrated in caveolae. J Histochem Cytochem (1994) 4.61

Filipin-sensitive caveolae-mediated transport in endothelium: reduced transcytosis, scavenger endocytosis, and capillary permeability of select macromolecules. J Cell Biol (1994) 4.30

Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J Cell Biol (2001) 4.22

Dynamin at the neck of caveolae mediates their budding to form transport vesicles by GTP-driven fission from the plasma membrane of endothelium. J Cell Biol (1998) 3.99

Molecular imaging in drug discovery and development. Nat Rev Drug Discov (2003) 3.44

Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24

Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98

Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol Biol Cell (2002) 2.84

Dorsal skinfold chamber technique for intravital microscopy in nude mice. Am J Pathol (1993) 2.60

The next frontier of molecular medicine: delivery of therapeutics. Nat Med (1998) 2.59

Endothelial caveolae have the molecular transport machinery for vesicle budding, docking, and fusion including VAMP, NSF, SNAP, annexins, and GTPases. J Biol Chem (1995) 2.41

Caveolae: static inpocketings of the plasma membrane, dynamic vesicles or plain artifact? J Cell Sci (1988) 2.16

Role of GTP hydrolysis in fission of caveolae directly from plasma membranes. Science (1996) 1.95

Molecular imaging: looking at problems, seeing solutions. Science (2003) 1.93

Proteomics in diagnostic pathology: profiling and imaging proteins directly in tissue sections. Am J Pathol (2004) 1.76

Caveolae: mining little caves for new cancer targets. Nat Rev Cancer (2003) 1.76

Endothelial plasmalemmal vesicles as elements in a system of branching invaginations from the cell surface. Proc Natl Acad Sci U S A (1979) 1.62

Morphometric data on the endothelium of blood capillaries. J Cell Biol (1974) 1.62

Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci U S A (1999) 1.46

Immunotargeting of catalase to the pulmonary endothelium alleviates oxidative stress and reduces acute lung transplantation injury. Nat Biotechnol (2003) 1.46

Pulmonary drug delivery systems: recent developments and prospects. Crit Rev Ther Drug Carrier Syst (2002) 1.45

Structure of solid tumors and their vasculature: implications for therapy with monoclonal antibodies. Cancer Cells (1991) 1.45

Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery. Proc Natl Acad Sci U S A (2002) 1.43

Specific albumin binding to microvascular endothelium in culture. Am J Physiol (1988) 1.37

Caveolae: from basic trafficking mechanisms to targeting transcytosis for tissue-specific drug and gene delivery in vivo. Adv Drug Deliv Rev (2001) 1.28

Immunoisolation of caveolae with high affinity antibody binding to the oligomeric caveolin cage. Toward understanding the basis of purification. J Biol Chem (1999) 1.26

Targeted vectors for gene therapy. FASEB J (1995) 1.18

Vascular targeting as a strategy for cancer therapy. N Engl J Med (1998) 1.14

Endothelial transport of macromolecules: transcytosis and endocytosis. A look from cell biology. Cell Biol Rev (1991) 1.09

Vascular targeting--a new approach to the therapy of solid tumors. Pharmacol Ther (1994) 1.08

Fc receptors of liver sinusoidal endothelium in normal rats and humans. A histologic study with soluble immune complexes. Gastroenterology (1987) 1.04

Delivery systems intended for in vivo gene therapy of cancer: targeting and replication competent viral vectors. Crit Rev Oncol Hematol (2001) 1.04

Monoclonal antibody targeting of liposomes to mouse lung in vivo. Cancer Res (1989) 1.01

Update on the cellular and molecular basis of capillary permeability. Trends Cardiovasc Med (2011) 0.99

Caveolae require intact VAMP for targeted transport in vascular endothelium. Am J Physiol (1999) 0.98

Iodination of annexin V for imaging apoptosis. J Nucl Med (2002) 0.92

Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration. Microvasc Res (2005) 0.91

Real time in vivo quantitation of tumor angiogenesis. Methods Mol Med (2003) 0.89

Targeted adenoviral vectors for cancer gene therapy. Adv Exp Med Biol (1998) 0.88

Maturation of myocardial capillaries in the fetal and neonatal rat: an ultrastructural study with a morphometric analysis of the vesicle populations. Am J Anat (1987) 0.82

Pulmonary gene therapy. Realistic hope for the future, or false dawn in the promised land? Monaldi Arch Chest Dis (2003) 0.81

Articles by these authors

Topological domains in mammalian genomes identified by analysis of chromatin interactions. Nature (2012) 18.23

The Genome sequence of the SARS-associated coronavirus. Science (2003) 16.68

Scope and impact of financial conflicts of interest in biomedical research: a systematic review. JAMA (2003) 16.08

Genome-wide association study of 107 phenotypes in Arabidopsis thaliana inbred lines. Nature (2010) 10.66

Aberrant innate immune response in lethal infection of macaques with the 1918 influenza virus. Nature (2007) 10.40

Modelling schizophrenia using human induced pluripotent stem cells. Nature (2011) 7.41

A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A (2012) 6.27

Trends in survival after in-hospital cardiac arrest. N Engl J Med (2012) 5.67

Characterization of human metapneumoviruses isolated from patients in North America. J Infect Dis (2002) 5.64

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning. Nat Med (2003) 5.45

Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet (2007) 5.21

A high-resolution map of the three-dimensional chromatin interactome in human cells. Nature (2013) 5.18

Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science (2006) 4.71

Human illness from avian influenza H7N3, British Columbia. Emerg Infect Dis (2004) 4.29

Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial. Ann Surg Oncol (2011) 4.16

New world bats harbor diverse influenza A viruses. PLoS Pathog (2013) 4.10

Evaluation of ranolazine in patients with type 2 diabetes mellitus and chronic stable angina: results from the TERISA randomized clinical trial (Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina). J Am Coll Cardiol (2013) 3.90

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. Mol Cell (2005) 3.89

Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009: four observational studies from Canada. PLoS Med (2010) 3.85

Long-term outcomes in elderly survivors of in-hospital cardiac arrest. N Engl J Med (2013) 3.85

Epigenomic analysis of multilineage differentiation of human embryonic stem cells. Cell (2013) 3.81

Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol (2003) 3.51

Genetic variants and risk of lung cancer in never smokers: a genome-wide association study. Lancet Oncol (2010) 3.49

AMPylation of Rho GTPases by Vibrio VopS disrupts effector binding and downstream signaling. Science (2008) 3.44

Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension (2006) 3.42

Human Bocavirus infection, Canada. Emerg Infect Dis (2006) 3.30

Pre-existing AAV capsid-specific CD8+ T cells are unable to eliminate AAV-transduced hepatocytes. Mol Ther (2007) 3.26

Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature (2004) 3.24

A Pseudomonas syringae effector inactivates MAPKs to suppress PAMP-induced immunity in plants. Cell Host Microbe (2007) 3.15

The scale of population structure in Arabidopsis thaliana. PLoS Genet (2010) 3.12

PINK1 phosphorylates ubiquitin to activate Parkin E3 ubiquitin ligase activity. J Cell Biol (2014) 3.12

Triple reassortant H3N2 influenza A viruses, Canada, 2005. Emerg Infect Dis (2006) 3.05

Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol (2009) 3.01

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26. Nature (2013) 3.00

Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol (2004) 2.98

Identification of a novel astrovirus (astrovirus VA1) associated with an outbreak of acute gastroenteritis. J Virol (2009) 2.96

Prognostic value of a microRNA signature in nasopharyngeal carcinoma: a microRNA expression analysis. Lancet Oncol (2012) 2.91

Novel avian influenza H7N3 strain outbreak, British Columbia. Emerg Infect Dis (2004) 2.90

Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension (2013) 2.89

Pseudomonas syringae effector AvrPto blocks innate immunity by targeting receptor kinases. Curr Biol (2007) 2.84

Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow. Cell (2008) 2.84

Anterior chamber width measurement by high-speed optical coherence tomography. Ophthalmology (2005) 2.77

Significance of white-coat hypertension in older persons with isolated systolic hypertension: a meta-analysis using the International Database on Ambulatory Blood Pressure Monitoring in Relation to Cardiovascular Outcomes population. Hypertension (2012) 2.75

Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinoma. Nat Med (2013) 2.70

Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet (2005) 2.68

Progressive ganglion cell loss and optic nerve degeneration in DBA/2J mice is variable and asymmetric. BMC Neurosci (2006) 2.68

Prognostic value of reading-to-reading blood pressure variability over 24 hours in 8938 subjects from 11 populations. Hypertension (2010) 2.64

Amplification of LAPTM4B and YWHAZ contributes to chemotherapy resistance and recurrence of breast cancer. Nat Med (2010) 2.62

Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation. Nat Biotechnol (2004) 2.60

Clinical and molecular characterisation of hereditary dopamine transporter deficiency syndrome: an observational cohort and experimental study. Lancet Neurol (2010) 2.60

Component-specific effectiveness of trivalent influenza vaccine as monitored through a sentinel surveillance network in Canada, 2006-2007. J Infect Dis (2009) 2.59

A decade's studies on metastasis of hepatocellular carcinoma. J Cancer Res Clin Oncol (2003) 2.50

Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009. BMJ (2011) 2.50

Correlation of IHC and FISH for ALK gene rearrangement in non-small cell lung carcinoma: IHC score algorithm for FISH. J Thorac Oncol (2011) 2.50

miR-301a as an NF-κB activator in pancreatic cancer cells. EMBO J (2010) 2.47

A coastal cline in sodium accumulation in Arabidopsis thaliana is driven by natural variation of the sodium transporter AtHKT1;1. PLoS Genet (2010) 2.45

Prevention of stroke and myocardial infarction by amlodipine and Angiotensin receptor blockers: a quantitative overview. Hypertension (2007) 2.43

Two calcium-dependent protein kinases, CPK4 and CPK11, regulate abscisic acid signal transduction in Arabidopsis. Plant Cell (2007) 2.40

Genome sequencing and comparison of two nonhuman primate animal models, the cynomolgus and Chinese rhesus macaques. Nat Biotechnol (2011) 2.37

Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. Blood (2007) 2.35

Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women. Hypertension (2011) 2.33

beta-catenin interacts with and inhibits NF-kappa B in human colon and breast cancer. Cancer Cell (2002) 2.33

Novel, chimpanzee serotype 68-based adenoviral vaccine carrier for induction of antibodies to a transgene product. J Virol (2002) 2.31

Pathogenesis of avian influenza (H7) virus infection in mice and ferrets: enhanced virulence of Eurasian H7N7 viruses isolated from humans. J Virol (2007) 2.30

Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens (2010) 2.28

A transforming metal nanocomposite with large elastic strain, low modulus, and high strength. Science (2013) 2.28

A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS One (2011) 2.23

Positional cloning of the murine flavivirus resistance gene. Proc Natl Acad Sci U S A (2002) 2.22

Effect of preexisting immunity to adenovirus human serotype 5 antigens on the immune responses of nonhuman primates to vaccine regimens based on human- or chimpanzee-derived adenovirus vectors. J Virol (2007) 2.18

Substantia nigra tangles are related to gait impairment in older persons. Ann Neurol (2006) 2.17

CHD1L promotes hepatocellular carcinoma progression and metastasis in mice and is associated with these processes in human patients. J Clin Invest (2010) 2.15

Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke (2009) 2.13

Treatment of long-lasting persistent atrial fibrillation using minimally invasive surgery combined with irbesartan. Ann Thorac Surg (2011) 2.11

Sensitive and broadly reactive reverse transcription-PCR assays to detect novel paramyxoviruses. J Clin Microbiol (2008) 2.10

An overview of anthrax infection including the recently identified form of disease in injection drug users. Intensive Care Med (2012) 2.10

Seizure-associated, aberrant neurogenesis in adult rats characterized with retrovirus-mediated cell labeling. J Neurosci (2007) 2.09

Comparative assessment of scoring functions on a diverse test set. J Chem Inf Model (2009) 2.09

Predictive role of the nighttime blood pressure. Hypertension (2010) 2.07

Potential bridges for HIV infection to men who have sex with men in Guangzhou, China. AIDS Behav (2006) 2.06

Urinary angiotensinogen excretion and ambulatory blood pressure. J Hypertens (2012) 2.04

The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol (2010) 2.04

Detection of airborne severe acute respiratory syndrome (SARS) coronavirus and environmental contamination in SARS outbreak units. J Infect Dis (2005) 2.03

Crop diversity for yield increase. PLoS One (2009) 2.02

High-speed optical coherence tomography of corneal opacities. Ophthalmology (2007) 2.02

Bacillus anthracis edema and lethal toxin have different hemodynamic effects but function together to worsen shock and outcome in a rat model. J Infect Dis (2007) 2.01

Chimpanzee adenovirus antibodies in humans, sub-Saharan Africa. Emerg Infect Dis (2006) 1.99

Lethality during continuous anthrax lethal toxin infusion is associated with circulatory shock but not inflammatory cytokine or nitric oxide release in rats. Am J Physiol Regul Integr Comp Physiol (2004) 1.97

Heterozygous deletion of mitotic arrest-deficient protein 1 (MAD1) increases the incidence of tumors in mice. Cancer Res (2007) 1.96

Sequence analysis of the N, P, M and F genes of Canadian human metapneumovirus strains. Virus Res (2003) 1.96

Human coronavirus NL63 infection in Canada. J Infect Dis (2005) 1.93

PB2 residue 158 is a pathogenic determinant of pandemic H1N1 and H5 influenza a viruses in mice. J Virol (2010) 1.91

Human metapneumovirus infection in the Canadian population. J Clin Microbiol (2003) 1.90

Human infection with a triple-reassortant swine influenza A(H1N1) virus containing the hemagglutinin and neuraminidase genes of seasonal influenza virus. J Infect Dis (2010) 1.87

Swine influenza (H3N2) infection in a child and possible community transmission, Canada. Emerg Infect Dis (2007) 1.86

Transcriptome sequencing and de novo analysis for Yesso scallop (Patinopecten yessoensis) using 454 GS FLX. PLoS One (2011) 1.86